LifeStance Health Group, Inc.
LFSTHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeLifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. Valued at $2.94B, LFST is a mid-cap name in its sector. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Market Cap
$2.94B
Beta
1.20
P/E (TTM)
128.50
P/E (Fwd)
19.51
EPS (TTM)
$0.06
EPS (Fwd)
$0.40
ROE
1.6%
ROA
1.4%
Cash
$194.8M
Total Debt
$476.8M
Free CF
$140.7M
52W Change
31.1%
Annual Financials
Cash vs Debt
On the balance sheet, LFST has $194.8M in cash with $476.8M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $140.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 1.6%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 1.4% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $859.5M (2022) to $1.42B (2025), reflecting a 66% increase over the period.
The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing LFST.